Discovering the anticancer potential of non-oncology drugs by systematic viability profilingSteven M. Corsello, Todd R. Golub, Mustafa Kocak et al.|Nature Cancer|2020Cited by 880
S2DV: converting SMILES to a drug vector for predicting the activity of anti-HBV small moleculesJinsong Shao, Li Wang, Qineng Gong et al.|Briefings in Bioinformatics|2021Cited by 26